Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Jane Hutt maintained the decision not to support a public inquiry stating that all of the relevant information was already in the public domain.
Published on:
29 July, 2024
In R (March) v Secretary of State for Health, the judgment refers to the Irish compensation scheme and notes that it was put in place on compassionate grounds "without legal liability on the part of the State".
Published on:
29 July, 2024
Following review by the Welsh Secretary of State, John Redwood, a draft letter from Welsh Office Health Service officials no longer accepted that "no-fault" compensation might be inevitable.
Published on:
29 July, 2024
In a paper Dr Fowler questioned the theory of a single unknown virus and postulated that "haemophiliac AIDS may require years of repeated treatment with large quantities of concentrate [and so] be a function of the concentrate itself rather than a specific agent transmitted by homosexuals with or 'incubating' AIDS".
Published on:
23 July, 2024
Professor Bartlett in his oral evidence to the Archer Inquiry recalled that Dr Galbraith repeated his advice orally to the CSM(B). He commented further that although there were, by May 1983, only a small proportion of recipients of Factor 8 concentrate who had developed AIDS "the risk may not have been small" and added that "I think this last piece of evidence about the risk is one where other experts at the time disagreed".
Published on:
23 July, 2024
Professor Tedder stated "in veterinary medicine, products from one country would not get through incoming Customs of another country in the way that concentrates have come into the human market for haemophiliacs in the UK".
Published on:
23 July, 2024
Lord Glenarthur's office asked for a "fairly full draft letter" to respond to a parliamentary question asked by Baroness Masham. The draft response from the Department included the note that "we have confirmed with American manufacturers that future supplies of Factor VIII for this country will be manufactured only from plasma collected in accordance with US Food and Drug Administration Regulations introduced in March this year".
Published on:
23 July, 2024
The result of the FDA meeting was reported by Dr Fowler in a memo. He noted that the possibility of banning all products made before the implementation of the March 1983 regulations was rejected.
Published on:
23 July, 2024
Dr Fowler argued that the 13 July 1983 CSM(B) recommendation implied that 'pre-March 83' material should be used until adequate supplies of 'post-March 83' material were available.
Published on:
23 July, 2024
In a memo to Dr Walford, Dr Fowler expressed concerns that US manufacturers "may try to dump blood products produced from plasma collected prior to the March 1983 FDA regulations on the UK market."
Published on:
23 July, 2024
In a letter Ken Milne (Haemophilia Society) stated that the Haemophilia Society should place less emphasis on NHS concentrate and plans for self-sufficiency.
Published on:
24 July, 2024
Dr Kernoff responded to the statement that American people with haemophilia who had been treated with commercial Factor 8 concentrates had low T4/T8 ratios by saying "haemophiliacs who had been treated with cryoprecipitate usually had normal ratios. None of the patients with low ratios had AIDS".
Published on:
24 July, 2024
The Morbidity and Mortality Weekly Report reported that there was highly likely to be a viral cause of AIDS, transmissible by sex.
Published on:
24 July, 2024
In a letter, Reverend Tanner asked Professor Bloom to attend the next Haemophilia Society meeting, at which the main subject would be a discussion about AIDS.
Published on:
24 July, 2024
In a letter, Dr Galbraith (Communicable Disease Surveillance Centre) raised concerns about the risk of AIDS from blood products from the US.
Published on:
24 July, 2024
In a journal article by Dr Lee and others it was reported that there was a correlation between receiving imported Factor 8 concentrate and having low T4/T8 ratios.
Published on:
24 July, 2024
In a letter, Professor Bloom stated there had not been any major change with the status of AIDS in the UK and did not think the recommendations of the World Federation of Haemophilia Medical Board should be circulated to Haemophilia Society members.
Published on:
24 July, 2024
In a letter to Reverend Tanner (Haemophilia Society), Professor Bloom informed him that there had been little further development on AIDS.
Published on:
24 July, 2024
Following an article in the Mail on Sunday titled "Hospitals using killer blood", Professor Bloom provided a draft note for circulation to the members of the Haemophilia Society concerning the AIDS situation.
Published on:
24 July, 2024
An update on AIDS was published in Haemofact on AIDS Release No. 3 by Dr Lee, which stated: "In Great Britain the number of haemophiliacs who have been reported with AIDS remain at 2. Thus the incidence is less than 1 in 1,000 patients at risk."
Published on:
24 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2203
Page
2204
Page
2205
Page
2206
Current page
2207
Page
2208
Page
2209
Page
2210
Page
2211
…
Next page
Next
Last page
Last